• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs

    EMA

    EMA recommends suspension of medicines - Micro Therapeutic Research Labs

    EMA

    EMA says CRO monitoring activity not location based

    IN PHARMATECHNOLOGIST

    EMA recommends suspension of medicines due to unreliable studies from Micro T.

    EMA

    EMA looks to suspend 331 drugs ‘misrepresentation of study data’ at Indian CRO

    IN PHARMATECHNOLOGIST

    EMA Calls to Suspend More Than 300 Drugs due to Unreliable Studies - Indian CRO

    RAPS

    Start of a review concerning the conduct of studies at Micro Therapeutic

    EMA

    EU regulators uncover data-integrity concerns at Indian CRO

    EMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.